Introduction

H
UMAN MILK INTAKE in early life has a major impact on the premature infant's health into early adulthood. 1 In preterm infants, human milk promotes full enteral feeding and protects against necrotizing enterocolitis, retinopathy of prematurity, and infection. [2] [3] [4] [5] Human milk positively affects the neurodevelopmental outcome of premature infants and decreases the risk of adolescent high blood pressure and thereby the risk of later cardiovascular disease. [6] [7] [8] [9] The adequacy of human milk in preterm infants is compromised by the variability in the nutritional and immunological components. 10 There is a large within-and betweenmother variability in the protein and energy content of human milk. 11 Additionally, contact with containers for human milk and storage in refrigerator or freezer affects its nutritional and immunological properties. 10, 12 Therefore, optimal handling and storage of human milk are critical to preserve the composition of the milk and maximize the nutritional and immunological benefit to the preterm infant. 13 When maternal milk (the infant's own mother's milk) is not available, provision of screened and pasteurized donor milk (human milk given by lactating women not biologically related to the recipient) with nutrient supplementation is the second best option for the preterm infant. 14 The Holder pasteurization technique most commonly used (62.5°C for 30 minutes) effectively eliminates most potential virus contaminants as well as tuberculosis (TB) and other bacterial contaminants. 15 However, the Holder process results in a variable loss of nutritional and immunological components in breastmilk that may affect infant nutrition and defense against infection. 16 In Sweden there is a long tradition to feed preterm infants donor milk if maternal milk is not available. In most neonatal units donor milk is pasteurized before feeding, whereas feeding of fresh maternal milk is permitted. Current recommendations for the use of breastmilk were published by the Swedish National Board of Health and Welfare (SNBHW) in 1998. 17 In these guidelines it is recommended that all donors submit a full health and risk history. Donors should not have received an organ or tissue blood transfusion for the last 12 months. They should not smoke, use excess alcohol, or abuse drugs. Women with history of intravenous drug abuse and immigrants from high risk endemic areas for human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis B virus (HBV), and hepatitis C virus (HCV) should not be recruited as donors. All donors should have a test negative for antibodies to HIV, HTLV, and HCV as well as hepatitis B surface antigen within 3 months before donation. Additionally, a chest X-ray of breastmilk donors should be performed to exclude active ongoing TB. Before acceptance, donated milk should be cultured and proved to be free of pathogenic bacteria and have a content of less than 10,000 colony-forming units (CFU)/mL of Staphylococcus aureus and less than 100 CFU/mL of Enterobacteriaceae. Breastmilk from donors should always be pasteurized before use, preferably with Holder pasteurization. Although 10 years old now, these guiding principles are comparable with the updated national guidelines regarding the use of banked human milk in the United Kingdom 18 and those from the Human Milk Banking Association of North America. 14 In 2001 a network called Milknet was established in Sweden. A representative group of neonatal staff from all neonatal units in Sweden have met yearly to discuss questions regarding the use of maternal milk and donor milk. Consequently, a subgroup of this network has now proposed updated guidelines for breastmilk handling routines that will shortly be introduced. The aim of this study was to docu-OMARSDOTTIR ET AL. 166 
Materials and Methods
In Sweden the medical care of preterm infants is concentrated at 36 neonatal units. The gestational age of preterm infants treated at these neonatal units depends on the level of the intensive care in the unit, with the tertiary care neonatal units treating infants from the age of 22-23 gestational weeks.
Most neonatal units are associated with a milk bank located in the neonatal unit, in the hospital, or in a hospital nearby. In the milk banks, the recruitment and screening of donors takes place, and donor milk is collected, screened, processed, stored, and distributed as needed. Additionally, most neonatal units have a separately located milk kitchen in the unit where the storage, preparation, and handling of maternal milk take place and in some instances also the storage and preparation of donor milk.
In November 2006 and February 2007, a questionnaire about breastmilk use was issued to all the neonatal units in Sweden. The questions concentrated on the screening of the donors, the processing and nutrification of donor milk and maternal milk, and questions about the handling and use of breastmilk in the units.
The questionnaire was answered and returned by all neonatal units. Missing data in the form were supplemented in May 2007 by telephone interviews with the neonatal staff that had responded to the questionnaire. Because of the descriptive design of this study, no statistical analysis of the received data was performed.
Results
All 36 neonatal units in Sweden participated in the study. Twenty-seven neonatal units had their own milk bank located either in the unit or locally in the hospital. An assistant nurse was in charge in most of the milk banks (Table 1) .
Donor milk
In 25 of the 27 (93%) milk banks, donors submitted a health declaration to be approved before breastmilk donation could 
Bacterial count limits (CFU/mL)
be started. In all milk banks, donors were screened by blood test for HIV. Other screening procedures in the milk banks were blood test of donors for HTLV, HBV and HCV, a chest X-ray to exclude active TB, and a bacterial culture of donor's milk ( Fig. 1 and Table 2 ). Donor milk was routinely heat-treated before use in 22 of 27 (81%) milk banks. In 18 of these milk banks, donor milk was heated to 62.5°C for 30 minutes (Holder pasteurization), whereas in one of the milk banks, donor milk was heated to 72°C for 30 minutes. In the three remaining milk banks, donor milk was heated for 15 seconds to 72°C (two milk banks) and 73°C (one milk bank), respectively.
Infants with a gestational age Ͻ32 weeks were fed donor milk in all neonatal units treating these infants. In some units, all infants irrespective of gestational age were fed donor milk either as a complement to maternal milk or exclusively if maternal milk was unavailable. Only two of the participating neonatal units never had donor milk accessible in the unit.
Breastmilk donors received a payment of 100-200 Swedish Crowns ($17-33 US) per liter of donated milk. In times of scarcity, some neonatal units sold donor milk to other units after its processing. The price for donor milk after pasteurization and nutritional analysis ranged from 500 to 1,000 Swedish Crowns ($84-167 US) per liter.
Maternal milk
In 11 of the 36 (31%) neonatal units maternal milk to preterm infants was routinely frozen to reduce cytomegalovirus (CMV) transmission (Table 3) . In all other units preterm infants were fed fresh maternal milk as soon as it was available. No unit pasteurized or performed bacterial culture on maternal milk.
Nutritional aspects
A nutritional analysis of donor milk was performed in 17 of the 27 (63%) milk banks, whereas 25 of the 36 (69%) participating neonatal units analyzed maternal milk ( Table 4) . The milk banks at Borås Hospital and Sahlgrenska Hospital analyzed their milk with their own infrared milk analyzer (MilkoScan™ 133, Foss Electric, Hillerød, Denmark). The milk bank at Sahlgrenska Hospital also performed the milk analysis for Trollhättan Hospital, Skövde Hospital, and Möl-ndal Hospital. The remaining milk banks and neonatal units sent their milk to Steins Laboratory in Jönköping, Sweden for infrared analysis (MilkoScan 4000). The amount of protein, lactose, and fat in the breast milk was determined, and the total energy content in the milk was calculated.
All donor milk was enriched according to nutritional analysis or blindly. Maternal milk was enriched according to nutritional analysis or blindly in relation to the infant's growth. Most neonatal units enriched donor and maternal milk for infants with a gestational age Ͻ32 weeks or birth weight Ͻ1,500 g. The enrichment was initiated when the infants had reached full enteral feeds at the age of about 10-14 days. MiniMax ® (Novartis, Basel, Switzerland) or Enfamil ® (Mead Johnson Nutraceuticals, Evansville, IN) human milk fortifiers were the most frequently used products for combined energy, protein, and mineral enrichment in preterm infants. Calogen ® (Group DANONE SA, Paris, France), Liquigen ® (DANONE), Duocal ® (DANONE), or Duocal ® MCT (DANONE) was used when additive energy enrichment was needed. In those units where nutritional analysis of breastmilk was performed, the milk was enriched to achieve an intake of 3.5 g of protein/kg/day and 100-120 kcal/kg/day in the preterm infant. In those units where no nutritional analysis was performed, breastmilk enrichment was carried out blindly according to the prescriptions of the product used. In most neonatal units, enrichment of milk continued until the infant reached the age of 35 gestational weeks or the weight of 2,500 g, which often corresponded to the onset of breastfeeding. The maximum freezing time of both donor and maternal milk ranged from 3 to 6 months in the neonatal units (Table 4) .
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Hospital 2 days Յ30 weeks Umeå University Hospital 2 days Յ32 weeks Östersund Hospital 2 days Յ32 weeks Jönköping Hospital 3 days Յ32 weeks Växjö Hospital 3 days Յ30 weeks Örebro University Hospital 3 days Յ32 weeks Lund University Hospital 7 days Յ32 weeks
Discussion
This study confirms that in the majority of neonatal units in Sweden preterm infants born before the gestational age of 32 weeks are fed donor milk as a complement to maternal milk. In the majority of neonatal units, donor milk was pasteurized before feeding, whereas fresh maternal milk was permitted. Most of the neonatal units in Sweden had access to a milk bank. All breastmilk donors in Sweden were screened for HIV. In the majority of milk banks, donors were also screened for HBV and HBC, and a bacterial culture was performed of the donors' milk. More than half of the milk banks and neonatal units routinely performed nutritional analysis of donor and maternal milk, respectively.
In our study, none of the 27 milk banks completely followed the current Swedish national guidelines from 1998 regarding the recruitment of breastmilk donors and the handling of donor milk. In two of the 27 (7%) milk banks, donors were not given a health declaration in the recruitment process. A complete virological screening of breast milk donors for HIV, HTLV, HBV, and HCV was not performed in 13 (48%) of the milk banks. Donors were not screened for active lung TB with a chest Xray in 23 of the 27 (85%) milk banks. Donor milk was not routinely pasteurized in five of the 27 (19%) milk banks, and bacterial culture was not consistently performed on donated breastmilk in three (11%) of the participating milk banks.
The transmission of HIV and HTLV through breast milk is well documented. 19 Holder pasteurization is the method of choice to effectively eliminate HIV and HTLV. 15 In this study, however, two of the milk banks not performing screening of donors for HTLV did not routinely pasteurize donor breastmilk.
Five of the milk banks did not screen their donors for HBV and HCV. Transmission of HBV through breastmilk has been reported. 19, 20 Both anti-HCV antibody and HCV RNA have been detected in breastmilk of HCV-infected mothers, indicating risk of viral transmission through breast feeding. 21 As the effectiveness of Holder pasteurization against HBV and HCV in breastmilk has hitherto not been evaluated, consistent screening of breastmilk donors against these viruses is essential to avoid their transmission to donor milk recipients.
Twenty-four of the 27 (89%) milk banks routinely performed bacterial culture on donor breast milk. Conversely, only 15 (63%) of the milk banks completely followed the present guidelines regarding the acceptable bacterial count. However, pasteurization of donor breastmilk was performed in all milk banks not testing donor milk for bacterial growth.
In Sweden the incidence of TB is rising because of immigration of people from less developed countries. Despite this, the majority of milk banks in Sweden do not screen their donors for active TB with a chest X-ray. Transmission of TB through breastmilk has never been documented in the absence of TB mastitis, which is rare. 19, 22 However, donor milk could hypothetically become contaminated during breastmilk expression by respiratory tract droplets from a donor with active lung TB. 22 In addition, although pasteurization of donor milk kills TB bacteria effectively, this procedure may occasionally fail, resulting in a possible TB transmission. 15 The SNBHW guidelines recommend freezing of CMVseropositive maternal milk for preterm babies Ͻ32 weeks of gestational age. Freezing breastmilk at Ϫ20°C reduces CMV infectivity in vitro while sparing the biochemical and immunologic quality of human milk. 12, 23 In our study, 11 out of the 36 (31%) neonatal units routinely fed their preterm infants with freeze-thawed maternal milk in order to reduce the risk for breastmilk-induced CMV transmission. The time the mother's own breastmilk was kept frozen before use varied between the units from a few hours to 7 days. Today, it is still not known what time of period of freezing is needed to achieve full inactivation of CMV in breastmilk, and the efficacy of freeze-thawing to prevent severe CMV disease in preterm infants is currently debated. [24] [25] [26] [27] In preterm infants, the nutrient content of maternal milk may be inadequate. In addition, the variability in nutrient content results in unpredictable nutrient intakes for an infant who cannot be fed ad libitum. 28 Nutritional analysis of donor milk was performed in 17 (63%) of the milk banks, and in 22 (61%) neonatal units nutritional analysis of maternal milk was routinely performed. Because of the variations in the nutrient composition of human breastmilk, individualized protein and energy fortification of breastmilk after nutritional analysis is most desirable to improve nutrition in preterm infants. 29 
Conclusions
Human milk banking has an established role in the care of preterm infants in Sweden, but breastmilk handling routines for preterm infants differ among the neonatal units. New national guidelines can standardize the handling of human milk, thereby improving nutrition and minimizing the risk of breastmilk-induced infection in premature infants.
